Dr. Paul J. Mosca

My primary area of clinical interest is surgical oncology. My primary focus includes the care of patients with melanoma or other potentially aggressive skin or soft tissue tumors, as well as those in need of lymph node surgery. In addition to patient care and research, I am committed to education and training. It is important to me to be accessible, engaged, and thoughtful in my approach to interacting with patients, colleagues, learners, and other stakeholders. For me, a principle guiding force is a deep-seated belief in patient-centered, multidisciplinary, compassionate, state-of-the-art care that aims to serve our community and support the mission and values of Duke Health.

Dr. Mosca is rated as a Distinguished provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Lymphofollicular Hyperplasia, Pancreaticoduodenectomy, and Lymphadenectomy.

His clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 41 articles in the study of Melanoma.